학술논문

ACTIVExtend: 24 Months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
Document Type
Article
Source
In: Journal of Clinical Endocrinology and Metabolism. (Journal of Clinical Endocrinology and Metabolism, 2018, 103(8):2949-2957)
Subject
Language
English
ISSN
19457197
0021972X